SyrSpend® SF Fagron’s SyrSpend® SF Family of Products SyrSpend SF, Fagron’s Family of oral suspending vehicles, provides a unique formulation containing no methylcellulose or sorbitol. Because SyrSpend SF has low osmolality, pediatric, geriatric and other family members who have difficulty swallowing tablets or capsules can benefit from compounded suspensions. In addition to low osmolality (<50 mOsm), SyrSpend SF provides superior suspendability and palatability. SyrSpend SF can be flavored to patient preferences. The SyrSpend SF family includes SyrSpend SF liquid, SyrSpend SF preservative-free powder, and SyrSpend SF Alka, which contains an alkalinizing agent. Beyond Use Date in SyrSpend SF & SyrSpend SF Alka Vancomycin HCl Verapamil HCl Omeprazole Metronidazole Benzoate Oseltamivir Phosphate Gabapentin Ursodiol SyrSpend SF 90 Days 60 Days - 60 Days 30 Days 90 Days 66 Days SyrSpend SF Alka - - 90 Days - - - - (Above information is derived from stability studies which are available @ fagron.us or syrspendsf.com) fagron.us Fagron, Inc. - 2400 Pilot Knob Road - St. Paul, MN 55120 - USA Tel. (800) 423 6967 - Fax (800) 339 1596 Sugar-Free Alcohol-Free Gluten-Free Dye-Free
20ways Summer2013 Hospital Edition
To see the actual publication please follow the link above